News

Tell us about your exciting accomplishments!

OVPR staff is excited about the breakthroughs in research and scholarly accomplishments on our campus. If you have been awarded a grant, submitted a paper for publication or been notified that your research is being published in a scholarly journal, please contact us at hscora@ouhsc.edu so we can share the news with the rest of the OUHSC research community.

"The ORA submission process: A review for new investigators"
New PI Training 04-20-16 Final

Other helpful information

On this page, you will also find useful Institutional Data that you may be asked to provide when submitting a proposal.   Please let us know if there is additional information or links you would like to see on our site. Simply complete our Suggestion Form.

ORA Research News - Monday, February 26th, 2018

National Cancer Institute (NCI) – New Grant Mechanism that early-stage investigators

can use to extend the funding period of R10 Grants by up to two additional years.  For complete

information go to:

https://www.cancer.gov/grants-training/grants-funding/funding-opportunities/merit?cid=eb_govdel

 

 

Junior Faculty Funding Opportunities

The University of Oklahoma Health Sciences Center has a strong desire to support and develop

their junior faculty.   To accomplish this goal, a Committee has been formed to assist junior

researchers in identifying funding opportunities and is comprised of faculty from multiple

colleges and chaired by Dr. Jimmy Ballard.  The Committee has identified almost 300 funding

opportunities with updates occurring on a regular basis.  The data elements collected include

the following: key words; name of organization ;  name of award;  Internet link; description/

purpose;  application deadline; award amount; award length; requirements/eligibility; and

nomination of sponsor. Full details may be found at:  

Junior Faculty Funding Opportunies

 

 

IBEST-OUHSC Funding for Interdisciplinary ResearchRequest for Applications to

support collaborative research activities between OUHSC researchers and OU-Norman

researchers in the area of biomedical engineering - Deadline March 10, 2018

please see guidelines and face page attached

http://research.ouhsc.edu/Portals/1329/Assets/Documents/2017-IBEST-OUHSC-CollaborationAnnouncement_v1.docx?ver=2018-02-19-072831-840

http://research.ouhsc.edu/Portals/1329/Assets/Documents/2017-IBEST-OUHSC-CollaborationCover page_v1.docx?ver=2018-02-19-072831-840

 

National Science Foundation (NSF)does not tolerate sexual harassment or any kind of

harassment.  For complete information go to: https://www.nsf.gov/pubs/issuances/in144.jsp 

 

 

Online Partnership to Accelerate Research (OnPAR) - Leidos Health’s Life Sciences

has partnered with NIH to accelerate the biomedical research and development enterprise by

matching high-scoring (e.g., those within the 30th percentile), unfunded NIH applications with

private biomedical foundations and/or industries seeking to fund promising research via OnPAR. 

OnPAR member organizations are desperately seeking unfunded applications for:

  • Diabetes (1 and 2) and complications
  • Rheumatoid arthritis
  • Psoriasis
  • Systemic lupus erythematosus
  • Crohn’s disease
  • Ulcerative colitis
  • Ankylosing spondylitis
  • Psoriatic arthritis
  • Lupus nephritis
  • Atopic dermatitis
  • Alzheimer's
  • Parkinson’s
  • Wearable technologies and smartphone applications for early detection of  disease

initiation and progression

  • Acute myocardial infarction/ischemia-reperfusion therapies
  • Acute/ischemic stroke
  • Arrhythmia
  • Peripheral arterial disease

If your unfunded NIH application is within one-year of council review, you may receive

communication from NIH regarding OnPAR (see attachments on information sent to NIH

Program Officials).  NIH Program Officials will not be involved in the OnPAR process itself. 

Alternatively, you may contact OnPAR yourself if you feel that you qualify. For additional

information please go to: https://onpar.leidosweb.com/

 

 

Pre-Proposal Application for New Phase 1 COBRE Application

OUHSC is eligible to submit one new Phase 1 COBRE application for the January 24, 2019 deadline. 

The COBRE FOA can be found at: https://grants.nih.gov/grants/guide/pa-files/PAR-18-266.html

In order to select the most competitive PI and research theme for this COBRE application there will

be an internal competition as described in the attached Guidelines. 

The Pre-Proposal Application is due April 20, 2018.

http://research.ouhsc.edu/Portals/1329/Assets/Documents/COBRE Pre-proposal Guidelines.docx?ver=2018-01-16-073737-383

 

NIH NOTICES

 

Broad Agency Announcement: Vaccine Adjuvant Discovery Program NIAID-DAIT-NIHAI201700100

(NOT-AI-8-018)
https://grants.nih.gov/grants/guide/notice-files/NOT-AI-18-018.html

 

Broad Agency Announcement: Immune Mechanisms of Protection Against Mycobacterium Tuberculosis

Center (IMPAc-TB) NIAID-DAIT-NIHAI201700104 (NOT-AI-18-019)
https://grants.nih.gov/grants/guide/notice-files/NOT-AI-18-019.html

 

Notice of Intent to Publish a Funding Opportunity Announcement for Impact of Initial Influenza Exposure

on Immunity in Infants (U01 Clinical Trial Not Allowed) (NOT-AI-18-020)
https://grants.nih.gov/grants/guide/notice-files/NOT-AI-18-020.html

 

Notice of Interest in Advancing Research about the Effects of Opioids and Opioid Antagonists on the

Fetal and Neonatal Brain Development (NOT-DA-17-067)
https://grants.nih.gov/grants/guide/notice-files/NOT-DA-17-067.html

 

Notice of NIDA Participation in PA-18-653 "Developmentally Tailored HIV Prevention and Care

Research for Adolescents and Young Adults (R34 Clinical Trial Optional)" (NOT-DA-18-005)
https://grants.nih.gov/grants/guide/notice-files/NOT-DA-18-005.html

 

Notice of Corrected Application Date PAR-18-221, " Fast-Track Development of Medications to Treat

Cannabis Use Disorders UG3/UH3" (NOT-DA-18-006)
https://grants.nih.gov/grants/guide/notice-files/NOT-DA-18-006.html

 

Request for Proposals (RFP) Notice: Synthesis and Distribution of Drugs of Abuse and Related

Compounds (NOT-DA-18-061)
https://grants.nih.gov/grants/guide/notice-files/NOT-DA-18-061.html

 

Extending Deadline for RFA-FD-18-004 (NOT-FD-18-005)
https://grants.nih.gov/grants/guide/notice-files/NOT-FD-18-005.html

 

Notice of NIGMS Participation in PA-18-658 "Administrative Supplement for Research on Sex/Gender

Influences (Admin Supp - Clinical Trial Optional)" (NOT-GM-18-017)
https://grants.nih.gov/grants/guide/notice-files/NOT-GM-18-017.html

 

Request for Information (RFI): Research Specific to Pregnant Women and Lactating Women

(PRGLAC) (NOT-HD-18-003)
https://grants.nih.gov/grants/guide/notice-files/NOT-HD-18-003.html

 

Notice of NICHD Participation in PAR-18-411 "Getting To Zero: Understanding HIV Viral Suppression

and Transmission in the United States (R01 Clinical Trial Not Allowed)" (NOT-HD-18-004)
https://grants.nih.gov/grants/guide/notice-files/NOT-HD-18-004.html

 

Notice of Intent to Publish a Funding Opportunity Announcement for Cardiothoracic Surgical Trials

Network Renewal - CCC (U10 - Clinical Trials Required) (NOT-HL18-588)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-18-588.html

 

Notice of Correction to Application Instructions in RFA-HL-19-007: Limited Competition: Data Analysis

and Coordination Center for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS)

(U01 Clinical Trial Not Allowed) (NOT-HL-18-591)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-18-591.html

 

Notice of Correction to Application Instructions in RFA-HL-19-008: Limited Competition: Clinical

Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) (U01 Clinical

Trial Not Allowed) (NOT-HL-18-592)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-18-592.html

 

Notice of NIMH's Participation to PA-18-658, "Administrative Supplement for Research on Sex/

Gender Influences (Admin Supp Clinical Trial Optional) (NOT-MH-18-022)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-18-022.html

 

Notice of NINR involvement in RFA-TW-17-001 Health-Professional Education Partnership

Initiative (HEPI) (R25 - Clinical Trial Not Allowed) (NOT-NR-18-008)
https://grants.nih.gov/grants/guide/notice-files/NOT-NR-18-008.html

 

Notice of National Institute of Neurological Disorders and Stroke (NINDS) Interest in Biomarkers

Directed at Pain or Pain Therapies (NOT-NS-18-043)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-18-043.html

 

 

Please Note:  When only one application is allowed per Institution according to the sponsor

instructions, a one-page letter of intent summarizing the proposed project should be submitted

to the Vice President for Research at least one month prior to the application deadline (unless

otherwise noted).  The letters of intent will be reviewed and a single application will be chosen  

for submission from the University.

 

NIH DEADLINES

 

Towards Implementing Novel Training Methods to Enhance Cognition in Aging (U01 Clinical Trial

Required) (RFA-AG-18-031) – Deadline April 30, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-18-031.html

 

SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Focused Technologies

Toward Commercialization (R44 Clinical Trial Optional) (RFA-CA-18-011) – Deadline August 15, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-18-011.html

 

Exploiting Omics Assays to Investigate Molecular Regulation of Persistent HIV in Individuals with

Substance Use Disorder (R61/R33 Clinical Trial Optional) (RFA-DA-19-003) – Deadline July 17, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-003.html

 

Limited Competition: FaceBase 3: Craniofacial Development and Dysmorphology Data

Management and Integration Hub (U01 Clinical Trial Not Allowed) (RFA-DE-19-003)

Deadline July 17, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DE-19-003.html

 

Mass Spectrometric Assays for the Reliable and Reproducible Detection of Proteins/Peptides of

Importance in Type 1 Diabetes Research (U01 Clinical Trial Not Allowed) (RFA-DK-17-019)

Deadline July 10, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-17-019.html

 

Immune System Engineering For Targeted Tolerance in Type 1 Diabetes (R01 Clinical Trial Not

Allowed) (RFA-DK-17-020) – Deadline May 10, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-17-020.html

 

Discovery of Early Type 1 Diabetes Disease Biomarkers in the Human Pancreas [HIRN

Consortium on Beta Cell Death and Survival (CBDS)] (U01 - Clinical Trial Not Allowed)

(RFA-DK-17-021) – Deadline May 10, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-17-021.html

 

High-Resolution Exploration of the Human Islet Tissue Environment [HIRN Human Pancreas

Analysis Consortium (HPAC)] (U01 Clinical Trial Not Allowed) (RFA-DK-17-022)

Deadline May 10, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-17-022.html

 

Clinical, Behavioral and Physiological Research Testing Current and Novel Closed Loop

Systems (R01- Clinical Trial Required) (RFA-DK-17-023) – Deadline April 26, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-17-023.html

 

Impact of the Use of Glucose Monitoring and Control Technologies on Health Outcomes

and Quality of Life in Older Adults with Type 1 Diabetes (T1D) (R01 Clinical Trial Required)

(RFA-DK-17-024) – Deadline April 26, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-17-024.html

 

Development and Integration of Novel Components for Open and Closed Loop Hormone

Replacement Platforms for T1D Therapy (R01- Clinical Trial Optional) (RFA-DK-17-025)

Deadline May 10, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-17-025.html

 

Career Development Programs in Diabetes Research for Endocrinologists (K12 Clinical Trial

Optional) (RFA-DK-17-026) – Deadline April 26, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-17-026.html

 

Incorporating Patient-Reported Outcomes into Clinical Care for Type 1 Diabetes (R01 Clinical

Trial Required) (RFA-DK-17-027) – Deadline July 10, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-17-027.html

 

Treating Diabetes Distress to Improve Glycemic Outcomes in Type 1 Diabetes (R01 Clinical

Trial Required) (RFA-DK-17-028) – Deadline July 10, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-17-028.html

 

The Characterization and Discovery of Novel Autoantigens and Epitopes in Type 1 Diabetes

(R01 Clinical Trial Optional) (RFA-DK-17-031) – Deadline April 26, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-17-031.html

 

Funding For Collaborative Clinical Research In Type 1 Diabetes: Living Biobank (R01 Clinical

Trial Optional) (RFA-DK-17-032) – Deadline July 10, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-17-032.html

 

Elucidating the Effect of Glycemic Excursions on Patient Well-being and Cognitive Status in

People with Type 1 Diabetes (T1D) (R01 Clinical Trial Optional) (RFA-DK-18-003)

Deadline July 10, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-18-003.html

 

Development of New Technologies and Bioengineering Solutions for the Advancement of Cell

Replacement Therapies for Type 1 Diabetes (T1D) (R01 Clinical Trial Optional) (RFA-DK-18-004)

Deadline May 10, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-18-004.html

 

National Laboratory Curriculum Framework Development (RFA-FD-18-005) – Deadline April 20, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-18-005.html

 

Male and Female Contraceptive Development (R43/R44 Clinical Trial Optional) (RFA-HD-19-004)

Deadline April 16, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-19-004.html

 

National Research Mentoring Network (NRMN) Resource Center (U24 - Clinical Trial Not Allowed)

(RFA-RM-18-002) – Deadline June 11, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-18-002.html

 

National Research Mentoring Network (NRMN) Coordination Center (U24 - Clinical Trial Not

Allowed) (RFA-RM-18-003) – Deadline June 11, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-18-003.html

 

National Research Mentoring Network: The Science of Mentoring, Networking, and Navigating

Career Transition Points (U01 Clinical Trial Not Allowed) (RFA-RM-18-004) – Deadline June 11, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-18-004.html

 

Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults

(R01 Clinical Trial Optional) (PA-18-651) – Deadline June 5, 2018
https://grants.nih.gov/grants/guide/pa-files/PA-18-651.html

 

Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults

(R21 Clinical Trial Not Allowed) (PA-18-652) – Deadline June 16, 2018
https://grants.nih.gov/grants/guide/pa-files/PA-18-652.html

 

Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults

(R34 Clinical Trial Optional) (PA-18-653) – Deadline June 16, 2018
https://grants.nih.gov/grants/guide/pa-files/PA-18-653.html

 

Administrative Supplement for Research on Sex/Gender Influences (Admin Supp - Clinical Trial

Optional) (PA-18-658) – Deadline March 26, 2018
https://grants.nih.gov/grants/guide/pa-files/PA-18-658.html

 

Genetics of Alcohol Sensitivity and Tolerance (R01 Clinical Trial Not Allowed) (PA-18-660)

Deadline June 5, 2018
https://grants.nih.gov/grants/guide/pa-files/PA-18-660.html

 

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship

to Promote Diversity in Health-Related Research (Parent F31) (PA-18-666) – Deadline April 8, 2018
https://grants.nih.gov/grants/guide/pa-files/PA-18-666.html

 

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students

at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)

(PA-18-668) – Deadline April 8, 2018
https://grants.nih.gov/grants/guide/pa-files/PA-18-668.html

 

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship

(Parent F32) (PA-18-670) – Deadline April 8, 2018
https://grants.nih.gov/grants/guide/pa-files/PA-18-670.html

 

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship

(Parent F31) (PA-18-671) – Deadline April 8, 2018
https://grants.nih.gov/grants/guide/pa-files/PA-18-671.html

 

Basic Research in Cancer Health Disparities (R01 Clinical Trials Not Allowed) (PAR-18-654)

Deadline June 19, 2018
https://grants.nih.gov/grants/guide/pa-files/PAR-18-654.html

 

Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) (PAR-18-655)

Deadline June 19, 2018
https://grants.nih.gov/grants/guide/pa-files/PAR-18-655.html

 

NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative

Agreement (UG3/UH3 Clinical Trial Required) (PAR-18-656) – Deadline June 6, 2018
https://grants.nih.gov/grants/guide/pa-files/PAR-18-656.html

 

Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence

(U54 Clinical Trial Optional) (PAR-18-657) – Deadline September 11, 2018
https://grants.nih.gov/grants/guide/pa-files/PAR-18-657.html

.

Mechanisms of Alcohol Tolerance (R21/R33 Clinical Trial Not Allowed) (PAR-18-659)

Deadline June 16, 2018
https://grants.nih.gov/grants/guide/pa-files/PAR-18-659.html

 

Pathway and Target Identification for Alzheimers Disease Related Dementias (ADRDs)

(U01 Clinical Trial Not Allowed) (PAR-18-661) – Deadline April 16, 2018
https://grants.nih.gov/grants/guide/pa-files/PAR-18-661.html

 

Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and

Body Interventions (Collaborative UG3/UH3 Clinical Trial Required) (PAR-18-662)

Deadline June 1, 2018
https://grants.nih.gov/grants/guide/pa-files/PAR-18-662.html

 

Mind and Body Intervention Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 –

Clinical Trial Required) (PAR-18-663) – Deadline June 1, 2018
https://grants.nih.gov/grants/guide/pa-files/PAR-18-663.html

 

Clinical Validation of Candidate Biomarkers for Neurological Diseases (U01 Clinical Trial Optional)

(PAR-18-664) – Deadline April 17, 2018
https://grants.nih.gov/grants/guide/pa-files/PAR-18-664.html

 

NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research

(R44 Clinical Trial Optional) (PAR-18-665) – Deadline April 16, 2018
https://grants.nih.gov/grants/guide/pa-files/PAR-18-665.html

   

 

OTHER DEADLINES

 

College of Medicine Alumni Association (COMAA) – Deadline April 6, 2018

For additional information see the attachment.

http://research.ouhsc.edu/Portals/1329/Assets/Documents/COMAA_FOA_Ltr2018.doc?ver=2018-01-29-072944-313

 

Oklahoma Center for the Advancement of Science and Technology (OCAST)

Research Program – Deadline April 4, 2018

https://www.ok.gov/ocast/FUNDING_OPPORTUNITIES/Pro-Health.html

 

The Presbyterian Health Foundation will fund $3.4M in grants for 2018.  Following is information

on grant type, application due date, and location of guidelines and applications.

Grant Type

Cycle I

Due Date

Cycle II

Due Date

Cycle III

Due Date

Bridge

April 16

August 17

November 16

Seed

March 16

NA

NA

Team Science

March 16

NA

NA

Equipment

March 16

NA

NA

Symposium

March 16

NA

NA

Clinician Scientist Development

March 16

NA

NA

Guidelines and applications for each of these PHF grants can be found at:

http://research.ouhsc.edu/ResearchAdministration/Grants/FundingSources/PHFGrantInformation.aspx

 

Robert Wood Johnson Foundation (RWJF) – Opioid Challenge – Deadline March 22, 2018

https://www.rwjf.org/en/how-we-work/grants-explorer/funding-opportunities.html

 

RWJF – Clinical Scholars – Deadline March 14, 2018

https://www.rwjf.org/en/how-we-work/grants-explorer/funding-opportunities.html

 

 

New Clinical Study Opportunities

***************************************************

Please note this is NOT a solicitation for study subjects

***************************************************

Several Pharmaceutical companies are looking for Principal Investigators to participate in the

following clinical studies:

  • GSK Non-Hodgkin's Lymphoma 235112
  • Adult Asthma Study
  • Gastrointestinal Neoplasm Malignant Study
  • Solid Tumor Trial
  • Attention Deficit Hyperactivity Disorder (ADHD)#111435-427
  • Clinical Research in Type I Diabetes Mellitus #00111586
  • Phase 2 Ulcerative Colitis Clinical Trial 237705
  • Alzheimer's Disease Study

Please contact Scott Davis at scott-davis@ouhsc.edu if you would like to receive more

information on any of these studies. The resulting confidentiality and/or clinical study

agreement will need to be routed to the Office of Research Administration.

Print

Name:
Email:
Subject:
Message:
x